The effects of CGRP pathway monoclonal antibody treatment on inner ear function in patients with migraine: a prospective study
Not Applicable
- Conditions
- migraine
- Registration Number
- JPRN-UMIN000048360
- Lead Sponsor
- Tominaga Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
Treatment duration is less than 3 months The patients with migraine with brainstem aura
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method